PATENT CLAIM ANALYSIS

Application Number: 16001153
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "134100"]

Abstract:
Methods and compositions for clonally inhibiting or clonally stimulating T-cells are provided.

Claim (Index 102):
A multimeric polypeptide according to  claim 80 , wherein the multimeric polypeptide comprises a first and a second heterodimer, and\n wherein the first and second heterodimers are covalently bound by one or more disulfide bonds between the Ig Fc polypeptides of the first and second heterodimers.

Metadata:
- Claim Count in Document: 60.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14745170', '15040774', '12641095', '11409339', '12138867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7159121896984998
- 35 USC 102 Novelty (BERT): 0.5468720476147055
- Combined Prediction Score: 0.6990081754901204
- Mean Citation Score: 343.35596600000014
- Max Citation Score: 386.52847
- Similarity Product: 286.6552181134564

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test